The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study
Chemotherapies are still widely used in advanced breast cancer, specifically in patients with HER2-negative disease. This non-interventional real-world study assessed the utilization of nab-paclitaxel in a broad patient population with advanced breast cancer.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
19 June 2025
|
| In: |
Journal of cancer research and clinical oncology
Year: 2025, Jahrgang: 151, Heft: 6, Pages: 1-11 |
| ISSN: | 1432-1335 |
| DOI: | 10.1007/s00432-025-06246-2 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00432-025-06246-2 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s00432-025-06246-2 
|
| Verfasserangaben: | Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1935657348 | ||
| 003 | DE-627 | ||
| 005 | 20250912104236.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250912s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00432-025-06246-2 |2 doi | |
| 035 | |a (DE-627)1935657348 | ||
| 035 | |a (DE-599)KXP1935657348 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Schneeweiss, Andreas |d 1961- |e VerfasserIn |0 (DE-588)109972554 |0 (DE-627)632849630 |0 (DE-576)327251859 |4 aut | |
| 245 | 1 | 4 | |a The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study |c Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf |
| 264 | 1 | |c 19 June 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 12.09.2025 | ||
| 520 | |a Chemotherapies are still widely used in advanced breast cancer, specifically in patients with HER2-negative disease. This non-interventional real-world study assessed the utilization of nab-paclitaxel in a broad patient population with advanced breast cancer. | ||
| 650 | 4 | |a Advanced breast cancer | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Nab-paclitaxel | |
| 650 | 4 | |a Non-interventional study | |
| 650 | 4 | |a Real-world | |
| 700 | 1 | |a Fasching, Peter A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Thill, Marc |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Mackelenbergh, Marion |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marmé, Frederik |d 1974- |e VerfasserIn |0 (DE-588)132561972 |0 (DE-627)52394893X |0 (DE-576)299226549 |4 aut | |
| 700 | 1 | |a Tesch, Hans |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fehm, Tanja N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Park-Simon, Tjoung-Won |e VerfasserIn |4 aut | |
| 700 | 1 | |a Häberle, Lothar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Uhrig, Sabrina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tome, Oliver |e VerfasserIn |4 aut | |
| 700 | 1 | |a Spall, Thomas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Theuser, Anna-Katharin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ruebner, Matthias |e VerfasserIn |4 aut | |
| 700 | 1 | |a Belleville, Erik |e VerfasserIn |4 aut | |
| 700 | 1 | |a Wallwiener, Diethelm |e VerfasserIn |4 aut | |
| 700 | 1 | |a Brucker, Sara Y. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hartkopf, Andreas D. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cancer research and clinical oncology |d Berlin : Springer, 1979 |g 151(2025), 6, Artikel-ID 192, Seite 1-11 |h Online-Ressource |w (DE-627)253769515 |w (DE-600)1459285-X |w (DE-576)072578319 |x 1432-1335 |7 nnas |a The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study |
| 773 | 1 | 8 | |g volume:151 |g year:2025 |g number:6 |g elocationid:192 |g pages:1-11 |g extent:11 |a The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s00432-025-06246-2 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s00432-025-06246-2 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250912 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 132561972 |a Marmé, Frederik |m 132561972:Marmé, Frederik |d 60000 |d 61300 |d 50000 |e 60000PM132561972 |e 61300PM132561972 |e 50000PM132561972 |k 0/60000/ |k 1/60000/61300/ |k 0/50000/ |p 5 | ||
| 998 | |g 109972554 |a Schneeweiss, Andreas |m 109972554:Schneeweiss, Andreas |d 910000 |d 910400 |d 50000 |e 910000PS109972554 |e 910400PS109972554 |e 50000PS109972554 |k 0/910000/ |k 1/910000/910400/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1935657348 |e 4771154147 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1935657348"],"doi":["10.1007/s00432-025-06246-2"]},"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"19 June 2025"}],"name":{"displayForm":["Andreas Schneeweiss, Peter A. Fasching, Marc Thill, Marion van Mackelenbergh, Frederik Marme, Hans Tesch, Tanja N. Fehm, Tjoung-Won Park-Simon, Lothar Häberle, Sabrina Uhrig, Oliver Tome, Thomas Spall, Anna-Katharin Theuser, Matthias Ruebner, Erik Belleville, Diethelm Wallwiener, Sara Y. Brucker, Andreas D. Hartkopf"]},"recId":"1935657348","person":[{"given":"Andreas","role":"aut","family":"Schneeweiss","display":"Schneeweiss, Andreas"},{"display":"Fasching, Peter A.","family":"Fasching","given":"Peter A.","role":"aut"},{"family":"Thill","role":"aut","given":"Marc","display":"Thill, Marc"},{"display":"van Mackelenbergh, Marion","family":"van Mackelenbergh","role":"aut","given":"Marion"},{"family":"Marmé","given":"Frederik","role":"aut","display":"Marmé, Frederik"},{"display":"Tesch, Hans","given":"Hans","role":"aut","family":"Tesch"},{"family":"Fehm","given":"Tanja N.","role":"aut","display":"Fehm, Tanja N."},{"display":"Park-Simon, Tjoung-Won","role":"aut","given":"Tjoung-Won","family":"Park-Simon"},{"given":"Lothar","role":"aut","family":"Häberle","display":"Häberle, Lothar"},{"family":"Uhrig","role":"aut","given":"Sabrina","display":"Uhrig, Sabrina"},{"display":"Tome, Oliver","family":"Tome","role":"aut","given":"Oliver"},{"display":"Spall, Thomas","family":"Spall","given":"Thomas","role":"aut"},{"role":"aut","given":"Anna-Katharin","family":"Theuser","display":"Theuser, Anna-Katharin"},{"given":"Matthias","role":"aut","family":"Ruebner","display":"Ruebner, Matthias"},{"family":"Belleville","role":"aut","given":"Erik","display":"Belleville, Erik"},{"display":"Wallwiener, Diethelm","family":"Wallwiener","role":"aut","given":"Diethelm"},{"display":"Brucker, Sara Y.","role":"aut","given":"Sara Y.","family":"Brucker"},{"given":"Andreas D.","role":"aut","family":"Hartkopf","display":"Hartkopf, Andreas D."}],"title":[{"title":"The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study","title_sort":"efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA study"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"physDesc":[{"extent":"11 S.","noteIll":"Illustrationen"}],"relHost":[{"title":[{"title_sort":"Journal of cancer research and clinical oncology","subtitle":"official organ of the Deutsche Krebsgesellschaft","title":"Journal of cancer research and clinical oncology"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"titleAlt":[{"title":"Cancer research and clinical oncology"}],"note":["Gesehen am 19.03.25","Teils ungezählte Beil.: Supplement"],"physDesc":[{"extent":"Online-Ressource"}],"pubHistory":["Volume 93, issue 1 (January 1979)-"],"language":["eng","ger"],"id":{"zdb":["1459285-X"],"issn":["1432-1335"],"eki":["253769515"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedKey":"1979","publisher":"Springer","dateIssuedDisp":"1979-"}],"part":{"year":"2025","issue":"6","pages":"1-11","volume":"151","text":"151(2025), 6, Artikel-ID 192, Seite 1-11","extent":"11"},"recId":"253769515","disp":"The efficacy and therapy management of nab-paclitaxel in the real-world setting for patients with advanced breast cancer - the SERAPHINA studyJournal of cancer research and clinical oncology"}],"note":["Gesehen am 12.09.2025"]} | ||
| SRT | |a SCHNEEWEISEFFICACYAN1920 | ||